BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36771452)

  • 1. The Cytotoxic Effect of Curcumin in Rhabdomyosarcoma Is Associated with the Modulation of AMPK, AKT/mTOR, STAT, and p53 Signaling.
    Salucci S; Bavelloni A; Stella AB; Fabbri F; Vannini I; Piazzi M; Volkava K; Scotlandi K; Martinelli G; Faenza I; Blalock W
    Nutrients; 2023 Feb; 15(3):. PubMed ID: 36771452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin disrupts the Mammalian target of rapamycin-raptor complex.
    Beevers CS; Chen L; Liu L; Luo Y; Webster NJ; Huang S
    Cancer Res; 2009 Feb; 69(3):1000-8. PubMed ID: 19176385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LY294002 and metformin cooperatively enhance the inhibition of growth and the induction of apoptosis of ovarian cancer cells.
    Li C; Liu VW; Chan DW; Yao KM; Ngan HY
    Int J Gynecol Cancer; 2012 Jan; 22(1):15-22. PubMed ID: 22080879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin disrupts uterine leiomyosarcoma cells through AKT-mTOR pathway inhibition.
    Wong TF; Takeda T; Li B; Tsuiji K; Kitamura M; Kondo A; Yaegashi N
    Gynecol Oncol; 2011 Jul; 122(1):141-8. PubMed ID: 21450334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin downregulates the PI3K-AKT-mTOR pathway and inhibits growth and progression in head and neck cancer cells.
    Borges GA; Elias ST; Amorim B; de Lima CL; Coletta RD; Castilho RM; Squarize CH; Guerra ENS
    Phytother Res; 2020 Dec; 34(12):3311-3324. PubMed ID: 32628350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin inhibits the mammalian target of rapamycin-mediated signaling pathways in cancer cells.
    Beevers CS; Li F; Liu L; Huang S
    Int J Cancer; 2006 Aug; 119(4):757-64. PubMed ID: 16550606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin (CUMINUP60®) mitigates exercise fatigue through regulating PI3K/Akt/AMPK/mTOR pathway in mice.
    Hu M; Han M; Zhang H; Li Z; Xu K; Kang H; Zong J; Zhao F; Liu Y; Liu W
    Aging (Albany NY); 2023 Mar; 15(6):2308-2320. PubMed ID: 36988546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin analog, WZ37, promotes G2/M arrest and apoptosis of HNSCC cells through Akt/mTOR inhibition.
    Zhang Z; Lin R; Liu Z; Yan T; Xia Y; Zhao L; Lin F; Zhang X; Li C; Wang Y
    Toxicol In Vitro; 2020 Jun; 65():104754. PubMed ID: 31863822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin targets the AKT-mTOR pathway for uterine leiomyosarcoma tumor growth suppression.
    Wong TF; Takeda T; Li B; Tsuiji K; Kondo A; Tadakawa M; Nagase S; Yaegashi N
    Int J Clin Oncol; 2014 Apr; 19(2):354-63. PubMed ID: 23666561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin inhibits Akt/mammalian target of rapamycin signaling through protein phosphatase-dependent mechanism.
    Yu S; Shen G; Khor TO; Kim JH; Kong AN
    Mol Cancer Ther; 2008 Sep; 7(9):2609-20. PubMed ID: 18790744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin dually inhibits both mammalian target of rapamycin and nuclear factor-κB pathways through a crossed phosphatidylinositol 3-kinase/Akt/IκB kinase complex signaling axis in adenoid cystic carcinoma.
    Sun ZJ; Chen G; Zhang W; Hu X; Liu Y; Zhou Q; Zhu LX; Zhao YF
    Mol Pharmacol; 2011 Jan; 79(1):106-18. PubMed ID: 20959361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin-induced apoptosis in ovarian carcinoma cells is p53-independent and involves p38 mitogen-activated protein kinase activation and downregulation of Bcl-2 and survivin expression and Akt signaling.
    Watson JL; Greenshields A; Hill R; Hilchie A; Lee PW; Giacomantonio CA; Hoskin DW
    Mol Carcinog; 2010 Jan; 49(1):13-24. PubMed ID: 19676105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Arylthiazolidine-4-carboxylic acid amides (ATCAA) target dual pathways in cancer cells: 5'-AMP-activated protein kinase (AMPK)/mTOR and PI3K/Akt/mTOR pathways.
    Li CM; Narayanan R; Lu Y; Hurh E; Coss CC; Barrett CM; Miller DD; Dalton JT
    Int J Oncol; 2010 Oct; 37(4):1023-30. PubMed ID: 20811725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic lethal interaction between PI3K/Akt/mTOR and Ras/MEK/ERK pathway inhibition in rhabdomyosarcoma.
    Guenther MK; Graab U; Fulda S
    Cancer Lett; 2013 Sep; 337(2):200-9. PubMed ID: 23684925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of curcumin by modulation of apoptosis and autophagy in human lung cancer A549 cells through inhibiting PI3K/Akt/mTOR pathway.
    Liu F; Gao S; Yang Y; Zhao X; Fan Y; Ma W; Yang D; Yang A; Yu Y
    Oncol Rep; 2018 Mar; 39(3):1523-1531. PubMed ID: 29328421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor effects of curcumin in pediatric rhabdomyosarcoma in combination with chemotherapy and phototherapy in vitro.
    Sorg C; Schmid E; Bortel N; Fuchs J; Ellerkamp V
    Int J Oncol; 2021 Feb; 58(2):266-274. PubMed ID: 33491749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin inhibits migration and invasion of non-small cell lung cancer cells through up-regulation of miR-206 and suppression of PI3K/AKT/mTOR signaling pathway.
    Wang N; Feng T; Liu X; Liu Q
    Acta Pharm; 2020 Sep; 70(3):399-409. PubMed ID: 32074070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer.
    Shankar S; Srivastava RK
    Int J Oncol; 2007 Apr; 30(4):905-18. PubMed ID: 17332930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin induces autophagy, inhibits proliferation and invasion by downregulating AKT/mTOR signaling pathway in human melanoma cells.
    Zhao G; Han X; Zheng S; Li Z; Sha Y; Ni J; Sun Z; Qiao S; Song Z
    Oncol Rep; 2016 Feb; 35(2):1065-74. PubMed ID: 26573768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) pathways synergistically inhibits rhabdomyosarcoma cell growth in vitro and in vivo.
    Renshaw J; Taylor KR; Bishop R; Valenti M; De Haven Brandon A; Gowan S; Eccles SA; Ruddle RR; Johnson LD; Raynaud FI; Selfe JL; Thway K; Pietsch T; Pearson AD; Shipley J
    Clin Cancer Res; 2013 Nov; 19(21):5940-51. PubMed ID: 23918606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.